Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
1.370
-0.060 (-4.20%)
Nov 18, 2026, 4:00 PM EST - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $32.61 million as of November 18, 2026. It is the 32,899th most valuable company in the world and the 4,816th biggest in the United States. Its market cap has decreased by 67.83% in one year.
Market Cap
32.61M
Enterprise Value
-48.91M
1-Year Change
-67.83%
Global Rank
Country Rank
#4,816 United States
Category
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $32.61M, a decrease of -84.80%. That is a compound annual growth rate of -67.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 32.61M | -79.34% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRulya Therapeutics | 38.00M |
| Biomea Fusion | 37.70M |
| eXoZymes | 37.03M |
| Grace Therapeutics | 36.81M |
| ImageneBio | 36.32M |
| Serina Therapeutics | 36.07M |
| Veru Inc. | 35.46M |
| Telomir Pharmaceuticals | 35.44M |